Management of P Pulmonale

Understanding P Pulmonale as a Diagnostic Clue

The European Respiratory Society suggests that P pulmonale represents right atrial abnormality on ECG and serves as a marker of underlying pathology rather than a disease requiring direct intervention 1, 2, 3
The American College of Cardiology recommends using the term "right atrial abnormality" rather than outdated terminology like "P pulmonale," "right atrial enlargement," or "right atrial hypertrophy" 4

The European Respiratory Society recommends assessing for additional ECG features of pulmonary hypertension, including right axis deviation of QRS complex, right ventricular hypertrophy and strain patterns, right bundle branch block, and QRS and QTc prolongation 1, 2, 5
The American College of Cardiology suggests obtaining chest radiography to look for central pulmonary artery dilatation with peripheral vascular "pruning" and to assess for right atrial and right ventricular enlargement 5
The European Respiratory Society recommends performing transthoracic echocardiography to estimate systolic pulmonary artery pressure, evaluate right ventricular size and function, and screen for structural cardiac defects 1, 2, 6

The American College of Cardiology states that right heart catheterization is mandatory to confirm pulmonary hypertension and define the hemodynamic profile before initiating pulmonary arterial hypertension-specific therapy 5
The European Respiratory Society recommends measuring mean pulmonary artery pressure, pulmonary vascular resistance, pulmonary artery wedge pressure, and cardiac output during right heart catheterization 1, 2, 5

The American College of Cardiology recommends initiating pulmonary vasodilator therapy for pulmonary arterial hypertension based on functional class and hemodynamics 5
The European Respiratory Society suggests providing supplemental oxygen to maintain oxygen saturation and considering anticoagulation in idiopathic pulmonary arterial hypertension 1, 2

The American Journal of Respiratory and Critical Care Medicine recommends monitoring for development of atrial arrhythmias, which occur in 25% of pulmonary hypertension patients within 5 years and cause clinical deterioration 6
The European Respiratory Society suggests repeating echocardiography 3-4 months after initiating or changing therapy to assess treatment response and monitoring for development of atrial arrhythmias 1, 2